Simon® to Present at BofA Securities 2024 Global Real Estate Conference
Simon® to Present at BofA Securities 2024 Global Real Estate Conference
PR Newswire
INDIANAPOLIS, Sept. 4, 2024
INDIANAPOLIS, Sept. 4, 2024 /PRNewswire/ -- Simon®, a real estate investment trust engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations, announced today that the Company will present at the BofA Securities 2024 Global Real Estate Conference on Tuesday, September 10, 2024 at 10:20 a.m. Eastern Time.
A live audio webcast of the presentation will be accessible from the Investors section of the Company's website at investors.simon.com. An online replay will be available following the presentation at the same location.
About Simon
Simon® is a real estate investment trust engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations and an S&P 100 company (Simon Property Group, NYSE: SPG). Our properties across North America, Europe and Asia provide community gathering places for millions of people every day and generate billions in annual sales.
View original content to download multimedia:https://www.prnewswire.com/news-releases/simon-to-present-at-bofa-securities-2024-global-real-estate-conference-302238170.html
SOURCE Simon
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk